ATYR
aTyr Pharma
ATYR
ATYR
110 hedge funds and large institutions have $336M invested in aTyr Pharma in 2025 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5.06% more ownership
Funds ownership: 69.5% → 74.56% (+5.1%)
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
Holders
110
Holding in Top 10
2
Calls
$5.88M
Puts
$3.81M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$4.6M | |
| 3 | +$3.43M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.55M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.35M |
Top Sellers
| 1 | -$7.3M | |
| 2 | -$5.82M | |
| 3 | -$1.93M | |
| 4 |
Goldman Sachs
New York
|
-$1.36M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.29M |